UB Paderborn / Katalog / Suche / in CDI

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

Oral oncology, 2023-02, Vol.137, p.106248-106248, Article 106248

2023

Volltextzugriff (PDF)

Non-opioid analgesics and post-operative pain following transoral robotic surgery for oropharyngeal cancer

Journal of laryngology and otology, 2022-06, Vol.136 (6), p.527-534

2022

Volltextzugriff (PDF)

A report of a caliber-persistent labial artery accompanied by uncharacteristic symptomology

Journal of stomatology, oral and maxillofacial surgery, 2020-09, Vol.121 (4), p.465-466

2020

Volltextzugriff (PDF)

Facial Nerve Management in Geniculate Ganglion Hemangiomas

Journal of Neurological Surgery Part B: Skull Base, 2014, Vol.75 (S 02)

2014

Volltextzugriff (PDF)

Neuroendocrine Neoplasms of the Oropharynx—A Literature Review

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e52-e53

2022

Volltextzugriff (PDF)

A Vaccine (PDS0101) Alone or in Combination with Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

International journal of radiation oncology, biology, physics, 2024-04, Vol.118 (5), p.e21-e22

2024

Volltextzugriff (PDF)

Intramuscular Hemangioma of the Scalene Masquerading as a Paraganglioma: A Case Series

Journal of Neurological Surgery Part B: Skull Base, 2012, Vol.73 (S 02)

2012

Volltextzugriff (PDF)

Reliability of Cancer Recurrence Data: Institution Cancer Registry vs. Trained Chart Abstraction

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e359

2022

Volltextzugriff (PDF)

The Number of Radiographically Positive Lymph Nodes is Predictive of Survival in HPV-Associated Oropharyngeal Cancer and Further Stratifies Outcomes Beyond Clinical Staging Alone

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e18-e19

2022

Volltextzugriff (PDF)

30-Day Morbidity and Bleeding Rates Associated with Transoral Robotic Surgery for HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Retrospective Analysis of Two Prospective Adjuvant Radiotherapy Deescalation Trials (MC1273 & MC1675)

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e55-e56

2022

Volltextzugriff (PDF)

Comparisons of Patient-Reported Quality of Life and Swallowing Scores of Mucosal Sparing Radiation vs. Standard of Care for Oropharyngeal Tumors

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e315

2022

Volltextzugriff (PDF)

Patient Reported Outcomes (PROs) in MC1675, De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard of Care Adjuvant Radiation Therapy (SOC) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S25-S26

2022

Volltextzugriff (PDF)

Correlation and Prediction of Modified Barium Swallowing Study with Patient-Reported Outcomes (PROs) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e315-e316

2022

Volltextzugriff (PDF)

ctHPVDNA and Recurrence Risk in MC1675, a Secondary Analysis of a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.S26

2022

Volltextzugriff (PDF)

Speech and Swallowing Function Following De-Escalation Adjuvant Chemoradiotherapy or Standard of Care Adjuvant Therapy for HPV Associated Oropharyngeal Carcinoma: A Prospective Randomized Trial

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e53-e53

2022

Volltextzugriff (PDF)

Analysis of Outcomes by Smoking Status in a Phase III Trial of De-Escalated Adjuvant Chemoradiation Therapy in Human Papillomavirus (HPV(+)) Oropharyngeal Squamous Cell Carcinoma (OPSCC)

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e13-e13

2022

Volltextzugriff (PDF)

Non-Inferiority Margin and Nodal Analysis of De-Escalated Adjuvant Radiation Therapy (DART) for HPV-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675

International journal of radiation oncology, biology, physics, 2022-04, Vol.112 (5), p.e3-e4

2022

Volltextzugriff (PDF)

MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2021-12, Vol.111 (5), p.1324-1324

2021

Volltextzugriff (PDF)

Tumor Infiltrating Lymphocytes (TILs) and T Cell Fraction in Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.e409-e409

2021

Volltextzugriff (PDF)

Quantity of ctDNA by Risk Category for Post-Operative Patients with HPV Associated Oropharyngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1186-1187

2020

Volltextzugriff (PDF)

Long-Term Results for MC1273, A Phase II Evaluation of De-Escalated Adjuvant Radiation Therapy for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

International journal of radiation oncology, biology, physics, 2021-11, Vol.111 (3), p.S61-S61

2021

Volltextzugriff (PDF)

Detectable HPV ctDNA in Post-Operative Oropharyngeal Squamous Cell Carcinoma Patients is Associated With Progression

International journal of radiation oncology, biology, physics, 2019-11, Vol.105 (3), p.682-683

2019

Volltextzugriff (PDF)

Risk Factors for Disease Progression Following Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma (HPV-OSCC)

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1124-1124

2020

Volltextzugriff (PDF)

Toxicity, Swallow Function, and Quality of life on MC1273, a Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in HPV+ Oropharynx Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2018-04, Vol.100 (5), p.1310-1310

2018

Volltextzugriff (PDF)

Long-term Toxicity, Swallow Function, and Quality of Life on MC1273, a Phase II Study of Dose De-escalation for Adjuvant Chemoradiation in HPV-Positive Oropharyngeal Cancer (HPV-OPC)

International journal of radiation oncology, biology, physics, 2022-06

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

Non-opioid analgesics and post-operative pain following transoral robotic surgery for oropharyngeal cancer

A report of a caliber-persistent labial artery accompanied by uncharacteristic symptomology

Facial Nerve Management in Geniculate Ganglion Hemangiomas

Neuroendocrine Neoplasms of the Oropharynx—A Literature Review

A Vaccine (PDS0101) Alone or in Combination with Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Intramuscular Hemangioma of the Scalene Masquerading as a Paraganglioma: A Case Series

Reliability of Cancer Recurrence Data: Institution Cancer Registry vs. Trained Chart Abstraction

The Number of Radiographically Positive Lymph Nodes is Predictive of Survival in HPV-Associated Oropharyngeal Cancer and Further Stratifies Outcomes Beyond Clinical Staging Alone

30-Day Morbidity and Bleeding Rates Associated with Transoral Robotic Surgery for HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Retrospective Analysis of Two Prospective Adjuvant Radiotherapy Deescalation Trials (MC1273 & MC1675)

Comparisons of Patient-Reported Quality of Life and Swallowing Scores of Mucosal Sparing Radiation vs. Standard of Care for Oropharyngeal Tumors

Patient Reported Outcomes (PROs) in MC1675, De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard of Care Adjuvant Radiation Therapy (SOC) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Correlation and Prediction of Modified Barium Swallowing Study with Patient-Reported Outcomes (PROs) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

ctHPVDNA and Recurrence Risk in MC1675, a Secondary Analysis of a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Speech and Swallowing Function Following De-Escalation Adjuvant Chemoradiotherapy or Standard of Care Adjuvant Therapy for HPV Associated Oropharyngeal Carcinoma: A Prospective Randomized Trial

Analysis of Outcomes by Smoking Status in a Phase III Trial of De-Escalated Adjuvant Chemoradiation Therapy in Human Papillomavirus (HPV(+)) Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Non-Inferiority Margin and Nodal Analysis of De-Escalated Adjuvant Radiation Therapy (DART) for HPV-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675

MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma

Tumor Infiltrating Lymphocytes (TILs) and T Cell Fraction in Human Papillomavirus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma

Quantity of ctDNA by Risk Category for Post-Operative Patients with HPV Associated Oropharyngeal Squamous Cell Carcinoma

Long-Term Results for MC1273, A Phase II Evaluation of De-Escalated Adjuvant Radiation Therapy for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC)

Detectable HPV ctDNA in Post-Operative Oropharyngeal Squamous Cell Carcinoma Patients is Associated With Progression

Risk Factors for Disease Progression Following Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma (HPV-OSCC)

Toxicity, Swallow Function, and Quality of life on MC1273, a Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in HPV+ Oropharynx Squamous Cell Carcinoma

Long-term Toxicity, Swallow Function, and Quality of Life on MC1273, a Phase II Study of Dose De-escalation for Adjuvant Chemoradiation in HPV-Positive Oropharyngeal Cancer (HPV-OPC)

Suchergebnisse filtern